Skip to main content
. 2014 Oct 29;9(10):e111104. doi: 10.1371/journal.pone.0111104

Figure 2. TNF-α (A), IL-1β (B), p22phox (C) and eNOS (D) mRNA levels in control (C), aldosterone-salt-treated animals (ALDO), PASE (PASE), aldosterone-salt plus PASE treated animals (ALDO+PASE), spironolactone treated animals (SPIRO) and aldosterone-salt plus spironolactone (ALDO+SPIRO).

Figure 2

Data are expressed as mean ± SEM derived from 8 animals per group. *p<0.05 vs. C; †p<0.05 vs. ALDO.